Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -6.07% is 257% below its 5-year average of -1.70%, near the low end of its 5-year range (-7.31%–5.26%).
19.49% below its 12-month average of -5.08%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -0.58%.
RETURN ON ASSETS (ROA)
-6.07%
RETURN ON ASSETS (ROA) AVG TTM
-5.08%
RETURN ON ASSETS (ROA) AVG 3Y
-4.92%
RETURN ON ASSETS (ROA) AVG 5Y
-1.70%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-19.49%
CURRENT VS 3Y AVG
-23.44%
CURRENT VS 5Y AVG
-257.41%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-23.76%
median of 426 covered companies
CURRENT VS SECTOR MEDIAN
+74.45%
vs the sector median at left
AirSculpt Technologies, Inc.
Market Cap
$134.74M
Return on Assets (ROA)
-6.07%
TTM Avg
-5.08%
3Y Avg
-4.92%
5Y Avg
-1.70%
Market Cap
$130.05M
Return on Assets (ROA)
-73.85%
TTM Avg
-21.75%
3Y Avg
-19.65%
5Y Avg
-19.48%
Market Cap
$129.14M
Return on Assets (ROA)
-87.44%
TTM Avg
-86.57%
3Y Avg
-87.06%
5Y Avg
-85.09%
Market Cap
$128.24M
Return on Assets (ROA)
-31.33%
TTM Avg
-56.73%
3Y Avg
-59.49%
5Y Avg
-64.55%
Market Cap
$142.11M
Return on Assets (ROA)
-36.33%
TTM Avg
-27.39%
3Y Avg
-256.74%
5Y Avg
-207.88%
Market Cap
$142.49M
Return on Assets (ROA)
35.31%
TTM Avg
-14.11%
3Y Avg
-23.46%
5Y Avg
-20.68%
Market Cap
$125.27M
Return on Assets (ROA)
-1.70%
TTM Avg
-35.34%
3Y Avg
-51.03%
5Y Avg
-36.99%
Market Cap
$149.51M
Return on Assets (ROA)
-25.59%
TTM Avg
-36.78%
3Y Avg
-35.70%
5Y Avg
-27.05%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AirSculpt Technologies, Inc. (AIRS) | $134.74M | -6.07% | -5.08% | -4.92% | -1.70% |
| Freenome, Inc. (FRNM)vs › | $137.29M | N/A | N/A | N/A | N/A |
| Health Catalyst, Inc. (HCAT)vs › | $130.05M | -73.85% | -21.75% | -19.65% | -19.48% |
| Entera Bio Ltd. (ENTX)vs › | $129.14M | -87.44% | -86.57% | -87.06% | -85.09% |
| Cibus, Inc. (CBUS)vs › | $128.24M | -31.33% | -56.73% | -59.49% | -64.55% |
| Alpha Cognition Inc (ACOG)vs › | $142.11M | -36.33% | -27.39% | -256.74% | -207.88% |
| Fortress Biotech, Inc. (FBIOP)vs › | $142.49M | 35.31% | -14.11% | -23.46% | -20.68% |
| enGene Holdings Inc. (ENGN)vs › | $125.27M | -1.70% | -35.34% | -51.03% | -36.99% |
| Codexis, Inc. (CDXS)vs › | $149.51M | -25.59% | -36.78% | -35.70% | -27.05% |
| TuHURA Biosciences, Inc. (HURA)vs › | $119.09M | -96.49% | -109.25% | -126.41% | -190.40% |
ROA
-6.1%
ROE
-11.2%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -6.23% |
| 2024-12-31 | -3.93% |
| 2023-12-31 | -2.20% |
| 2022-12-31 | -7.31% |
| 2021-12-31 | 5.26% |
| 2020-12-31 | 4.22% |
| 2019-12-31 | -1.29% |
